Gordon Rees Scully Mansukhani, LLP · 5 hours ago
Civil Litigation Attorneys
Gordon Rees Scully Mansukhani is a national law firm with offices in all 50 states, seeking Civil Litigation Attorneys for their Philadelphia office. The role involves defense litigation across various practice areas, requiring strong litigation and research skills, with opportunities for client interactions and trial appearances.
Law Practice
Responsibilities
Handle assignments with minimal supervision
Engage in trial experience as needed
Participate in forward facing client interactions
Manage appearances at hearings, depositions, and trials
Demonstrate excellent litigation, writing, and persuasive speaking skills
Qualification
Required
At least 3 years of experience in civil litigation
Candidates must be licensed and admitted to practice in the State of Pennsylvania
Driven team players with excellent litigation, writing and persuasive speaking skills
Strong academic backgrounds and proven skills in research
Self-starter who is able to handle assignments with minimal supervision
Preferred
Trial experience
Benefits
Competitive compensation
Full benefits package
Eligibility for subjective and objective bonuses
Student debt repayment assistance
Company
Gordon Rees Scully Mansukhani, LLP
As the only full-service law firm with offices and attorneys in all 50 states, Gordon Rees Scully Mansukhani delivers maximum value to our clients by combining the resources of a national firm with the local knowledge of a regional firm.
H1B Sponsorship
Gordon Rees Scully Mansukhani, LLP has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (6)
2023 (2)
2022 (3)
2021 (2)
2020 (1)
Funding
Current Stage
Late StageRecent News
bloomberglaw.com
2024-03-08
2023-10-10
2023-09-12
Company data provided by crunchbase